ICLR
$162.05+0.12%
as of close, Oct 2, 2026
☾ AH $162.05 +0.12%
ICLR — ICON plc price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
Volume
100.0150.0200.0250.0300.0020.0M40.0M$162.05—20162019202120242026
2026-10-02
Price$162.05
MA20$151.95
MA50$156.54
Vol6.0M
Key stats
Price data
- Price
- $162.05
- Change YTD
- -11.07%
- Next earnings
- Oct 28, 2026
- Market cap
- 12.4B
- Enterprise value
- 14.8B
- Shares outstanding
- 76.6M
- 52W low
- $66.57
- 52W high
- $203.91
- From 52W high
- -20.53%
- From 52W low
- +143.43%
- 52W range
- 70%
- Beta
- 1.19
Volume
- Rel volume
- 0.76×
- 30D volume
- 886.3K
- 30D $ vol
- 148.8M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- −$2.3M
- Insider net 3M
- −$4.0M
- Insider net 1Y
- −$4.0M
Form 4 transactions by trade date, as filed; latest on file 2026-09-17.
Fundamentals
- Sales (ttm)
- 8.3B
- Sales/share
- $107.77
- EPS (ttm)
- $2.90
- FCF (ttm)
- 862M
- FCF/share
- $11.26
- Book value/share
- $120.07
- Net margin
- 2.78%
- ROE
- 2.49%
- ROA
- 1.41%
- Debt / equity
- 0.31×
- Current ratio
- 1.10
Growth (CAGR, ttm) · 10Y
- Sales
- +0.76%+2.15%+24.16%+18.01%
- Net income
- -69.00%-23.15%-7.15%-0.43%
- FCF
- -22.95%+26.96%+10.34%+14.15%
- Shares
- -5.19%-2.15%+7.72%+3.37%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- -67.44%-22.08%-13.96%-3.09%
- Sales/share
- +6.28%+4.39%+15.26%+14.16%
- FCF/share
- -18.73%+29.75%+2.43%+10.43%
- Book value/share
- +2.70%+4.79%+27.93%+24.07%
- Price
- -16.03%-12.65%-9.18%+7.67%
- Total return
- -16.03%-12.65%-9.18%+7.67%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 55.9×
- P/OI (ttm)
- 28.0×
- Fwd P/E
- 14.7×
- P/S (ttm)
- 1.5×
- P/B (mrq)
- 1.3×
- P/FCF (ttm)
- 14.4×
- EV/EBITDA (fy)
- 17.9×
- EV/Sales (ttm)
- 1.8×
- FCF yield (ttm)
- 6.95%
- Buyback yield (realized, 1y)
- 5.19%
- Shareholder yield (realized, 1y)
- 5.19%
- Buyback yield (cash, ttm)
- 6.04%
- Shareholder yield (cash, ttm)
- 6.04%
Vs own 10Y history
- P/E
- 87th
- P/OI
- 73rd
- P/S
- 7th
- P/B
- 7th
- P/FCF
- 13th
Bar = where today’s multiple sits in ICLR’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-02
1D
+0.12%
5D
-5.97%
1M
+1.38%
3M
-6.36%
YTD
-11.07%
1Y
-16.02%
5Y
-38.23%
Recent filings
- Sep 17Insider sale · Murphy Ronan Martin (Director) sold 5,005 shares for $876K at $175.00
- Sep 17Insider sale · McCague Eugene Pacelli (Director) sold 3,255 shares for $570K at $175.00
- Sep 16Insider sale · CLIMAX JOHN DR (Director) sold 5,005 shares for $876K at $175.00
- Sep 98-K · Report of a foreign private issuer
- Aug 208-K · Report of a foreign private issuer
Financial statements
Open full ICLR financials →Loading financial statements…
Related Health Care
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| NVS | Novartis AG | -13.21% | -0.04% |
| NVO | Novo Nordisk A/S | -20.21% | -0.21% |
| SNY | Sanofi ADS | -10.23% | -1.84% |
| GSK | GSK plc American Depositary Shares (Each representing two Ordinary Shares) | -6.76% | -0.32% |
| NTRA | Natera Inc. | +26.20% | +0.46% |
| ARGX | argenx SE American Depositary Shares | -12.90% | -1.79% |
| TAK | Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | -3.09% | +0.00% |
| TEVA | Teva Pharmaceutical Industries Limited American Depositary Shares | +5.44% | +0.56% |
